GlassScriptPhysician profile
Jennifer Rodriguez
NPI 1407142532
$1,904.62
in general payments reported to CMS, 2019-2025
8 companies · $1,558 in 2025
The $1,558 reported for 2025 was more than what 93% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.86 · 2022: $42.86 · 2023: $58.86 · 2024: $207 · 2025: $1,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,233 · Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,232.53 |
| Food and Beverage | $591.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,485.39 | 2025 | |
| Abiomed | $219.26 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.88 | 2021-2023 | Lifevest |
| Biosense Webster, INC. | $41.56 | 2025 | Soundstar |
| Edwards Lifesciences Corporation | $20.14 | 2023 | Hemosphere |
| La Jolla Pharmaceutical Company | $18.83 | 2024 | Giapreza |
| Csl Behring | $15.31 | 2023 | Kcentra |
| Janssen Pharmaceuticals, INC | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.